/C O R R E C T I O N — Ansell Healthcare/

MELBOURNE, May 4, 2010 - In the news release, "Ansell Launches World's First Antimicrobial Surgical
Glove" issued on 4 May 2010 05:00 GMT, by Ansell Healthcare over PR
Newswire, we are advised by a representative of the company that an extra "s"
was accidentally added in "World's" in the headline by PR Newswire prior to
distribution.

Complete, corrected release follows:

Ansell Launches World's First Antimicrobial Surgical Glove

Ansell today announced the launch of their new GAMMEX(R) Powder-Free
glove with AMT Antimicrobial Technology, at the Annual Congress of the Royal
Australasian College of Surgeons in Perth, Australia.

It is the first surgical glove which incorporates a proprietary
antimicrobial coating to provide an additional level of protection to
surgical staff against viruses and bacteria, in the event of a breach during
surgery.

The last decade has witnessed a rapid expansion of the medical gloves
market globally. Major drivers for this growth are improving healthcare
systems around the world and the increasing awareness by healthcare workers
that gloves offer an effective protective barrier against contamination from
bacteria and viruses. Ansell's new AMT Antimicrobial Technology reduces
surgical staff risks of exposure to blood-borne pathogens through a higher
level of protection.

Extensive in vitro laboratory testing showed that the antimicrobial
coating killed >99 per cent of Hepatitis C1 and 99 percent of HIV-1 (strain
Mn) within 60 seconds of exposure through a simulated glove breach.

GAMMEX(R) Powder-Free glove with AMT Antimicrobial Technology also kills
between 99.7% to >99.999% of 8 common healthcare infectious bacteria,
comprising gram-positive, gram-negative, and drug-resistant bacteria (e.g.
MRSA, VRE) within 60 seconds from exposure.

"Ansell's proprietary AMT Antimicrobial surgical glove technology is the
result of intensive and collaborative research, and demonstrates the
Company's ability for industry leading innovation and new product
development", says Magnus Nicolin, CEO of Ansell Ltd.

"It also underscores Ansell's commitment to continuously invest in
seeking optimal solutions to better protect healthcare professionals in a
world with an increasing number of high risk pathogens", he continues.

GAMMEX(R) Powder-Free glove with AMT Antimicrobial Technology features a
unique and proprietary inner coating, containing skin friendly agents and
chlorhexidine gluconate (CHG), an effective antimicrobial agent commonly
found in products such as antiseptics and mouthwash.

Ansell's AMT Antimicrobial Technology is a world first and is now being
launched in Australia. It will be progressively rolled out in all Ansell
markets

1, Tested versus Bovine Viral Diarrhea Virus (BVDV), a common surrogate
for Hepatitis C.

About Ansell

Ansell is a world leader in providing superior health and safety
protection solutions that enhance human well being. With operations in the
Americas, Europe and Asia Pacific, Ansell employs more than 10,000 people
worldwide and holds leading market positions in industrial and medical
gloves. Ansell is also a leading player in the household gloves and condom
market segment globally. Information on Ansell and its products can be found
at www.ansell.com.

Information for Media: International, Wouter Piepers, Director Global Communications, T +32-2-528-74-00, D +32-2-528-75-68, M +32-478-33-56-32, Email: wpiepers at eu.ansell.com; Australia, Helen McCombie, Citadel PR, T +61-2-9290-3033, D +61-2-9290-3073, M 0411-756-248, Email: hmccombie at citadelpr.com.au; Information for Investors and Analysts: International, Rustom Jilla, Chief Financial Officer, Tel: (1732)345-5359, Email: rjilla at ansell.com; Australia, David Graham, General Manager - Finance & Treasury, Tel: (613)9270-7215, Email: dgraham at ap.ansell.com